ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,260Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 288

$505K Total Retail Price of All Prescriptions

Rank: 69 out of 288

309 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 309 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 309 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,950 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 471 391 1 1
HYDROCODONE-ACETAMINOPHEN 449 219 S3 2 7
LEVOTHYROXINE SODIUM 360 269 3 2
OMEPRAZOLE 332 238 4 3
AMLODIPINE BESYLATE 323 240 5 6
LISINOPRIL 284 206 6 4
FUROSEMIDE 269 203 7 5
METOPROLOL TARTRATE 237 198 8 8
MELOXICAM 214 153 9 44
HYDROCHLOROTHIAZIDE 206 150 10 13
METFORMIN HCL 198 168 11 12
ZOLPIDEM TARTRATE 188 116 12 22
POTASSIUM CHLORIDE 160 115 13 11
TRAMADOL HCL 141 95 14 19
TAMSULOSIN HCL 141 112 14 24
ALLOPURINOL 137 121 16 23
NEXIUM 133 49 17 43
PROAIR HFA 129 95 18 45
PRAVASTATIN SODIUM 114 110 19 21
CITALOPRAM HBR 113 80 20 18
CRESTOR 111 67 21 26
CYCLOBENZAPRINE HCL 104 49 R 22 73
METOPROLOL SUCCINATE 101 87 23 15
GLIMEPIRIDE 88 87 24 32
GABAPENTIN 84 26 25 17
SPIRONOLACTONE 83 64 26 36
ATENOLOL 83 62 26 10
WARFARIN SODIUM 81 51 28 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 67 29 34
HYDROMORPHONE HCL 78 0 S2 30 140
TRAZODONE HCL 76 27 31 37
OXYCODONE HCL 75 16 S2 32 127
TIZANIDINE HCL 73 44 33 226
LOSARTAN POTASSIUM 71 36 34 16
CLOPIDOGREL 70 70 35 47
IBUPROFEN 66 31 36 111
LEVOFLOXACIN 65 43 37 80
SPIRIVA 62 40 38 48
AZITHROMYCIN 62 39 38 49
CYMBALTA 60 43 40 67
DIOVAN 59 48 41 53
GLYBURIDE 59 59 R 41 59
CARVEDILOL 59 40 41 27
PANTOPRAZOLE SODIUM 58 41 44 42
DOXAZOSIN MESYLATE 56 37 45 78
ADVAIR DISKUS 56 17 45 50
RANITIDINE HCL 56 30 45 33
PLAVIX 56 44 45 71
ATORVASTATIN CALCIUM 55 39 49 14
FAMOTIDINE 53 51 50 68
METOCLOPRAMIDE HCL 52 17 51 128
ALENDRONATE SODIUM 51 51 52 20
FENTANYL 51 11 S2 52 57
DIOVAN HCT 51 43 52 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.